Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00288262 · ClinicalTrials.gov registry record · Phase 1
Melatonin Effects on Luteinizing Hormone
A Phase 1 study, sponsored by Scripps Health.
- Terminated
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00288262 is a Phase 1 study that was terminated before completion, run by Scripps Health. The registered enrollment target is 20 participants.
The verdict
NCT00288262, a Phase 1 study, was terminated before completion, sponsored by Scripps Health.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
In many mammals, the duration of the nocturnal melatonin elevation regulates seasonal changes in reproductive hormones such as luteinizing hormone (LH). Melatonin's effects on human reproductive endocrinology are uncertain. It is thought that the same hypothalamic pulse generator may both trigger the pulsatile release of GnRH and LH and also cause hot flashes. Thus, if melatonin suppressed this pulse generator in postmenopausal women, it might moderate hot flashes. This clinical trial tested the hypothesis that melatonin could suppress LH and relieve hot flashes.
Interventions
- DRUG melatonin 0.5 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2004-06 |
| Est. Completion | 2005-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00288262
The ClinicalTrials.gov registry entry for NCT00288262 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scripps Health, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which melatonin 0.5 mg is the first listed.
NCT00288262 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00288262 about?
NCT00288262 is a clinical study titled "Melatonin Effects on Luteinizing Hormone". In many mammals, the duration of the nocturnal melatonin elevation regulates seasonal changes in reproductive hormones such as luteinizing hormone (LH). Melatonin's effects on human reproductive endocrinology are uncertain. It is thought that the same hypothalamic pulse generator may both trigger th...
What is the current status of trial NCT00288262?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2004-06. Estimated completion is 2005-02.
What interventions are being tested in trial NCT00288262?
The interventions under investigation include: melatonin 0.5 mg (DRUG).
Who is sponsoring clinical trial NCT00288262?
This trial is sponsored by Scripps Health, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.